Evelo Biosciences (EVLO) Q4 2022 Earnings Report
EVLO Q4 2022 EPS Results
- Actual EPS
- -$4.20
- Consensus EPS
- -$5.50
- Beat/Miss
- Beat by +$1.30
- One Year Ago EPS
- -$10.80
EVLO Q4 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/16/2023
- Time
- Before Open
- Conference Call
- Thursday, March 16, 2023
Q4 2022 Earnings Call Audio
EVLO Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
EVLO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 01, 2024 | 2024 (Q2) | ―- | -3.78 | ― | |
| May 30, 2024 | 2024 (Q1) | ―- | -4.58 | ― | |
| Feb 15, 2024 | 2023 (Q4) | -1.27- | -4.2 | ― | |
| Nov 02, 2023 | 2023 (Q3) | -1.07-0.71 | -5.6 | 87.30% (+4.89) | |
| Aug 14, 2023 | 2023 (Q2) | -3.26-3.78 | -8 | 52.75% (+4.22) | |
| Jun 01, 2023 | 2023 (Q1) | -3.65-4.60 | -11.2 | 58.93% (+6.60) | |
| Mar 16, 2023 | 2022 (Q4) | -5.50-4.20 | -10.8 | 61.11% (+6.60) | |
| Nov 14, 2022 | 2022 (Q3) | -6.33-5.60 | -12.6 | 55.56% (+7.00) | |
| Aug 11, 2022 | 2022 (Q2) | -8.27-8.00 | -11.8 | 32.20% (+3.80) | |
| May 12, 2022 | 2022 (Q1) | -11.28-11.20 | -9.71 | -15.32% (-1.49) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
